Recursion Pharmaceuticals, Inc. RXRX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s earnings yield?
- Recursion Pharmaceuticals, Inc. (RXRX) reported earnings yield of -34.5% in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s earnings yield changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s earnings yield decreased by 27.7% year-over-year, from -27% to -34.5%.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s earnings yield?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s earnings yield has grown at a 47.6% compound annual growth rate (CAGR), from -6.4% to -30.3%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.